AstraZeneca plc
AstraZeneca plc is a high-Gold company driven by both system quality and unusual credibility strength. P1 and P7 are retained at L5 — the only company in the series with a CDP full A score, validated SBTi net-zero (2045), a C-suite CSO on the Senior Executive Team, a standalone Board Sustainability Committee, and no material greenwashing controversies, strategy walkbacks, or lobbying contradictions. The Ambition Zero Carbon programme has delivered a 68.5% Scope 1+2 reduction vs 2015, with RE100 membership (>98% renewable electricity), an EV fleet at >75%, and the AZ Forest programme (200M trees by 2030). Next-generation near-zero GWP inhalers (Phase III) would eliminate the largest single Scope 3 source. P2 and P3 are the only redlines — ISO 50001 is not universal, ICP at $100/t is below best-in-class peers, and the $1B sustainability bond is moderate for AZ’s scale. The smallest downgrade in the series (-5.7 pts) reflects a profile where credibility reinforces capability.
Technical assessment based on primary disclosures
Primary Data Source
Assurance Verification
Benchmarking Confidence
Pillar Performance
Assessment
Pillar Performance
Governance Chassis
Data Infrastructure
Financial Controls
Operational Linkage
Risk Radar
Assurance Depth
Transparency & Disclosure
Index Disclaimer
RECI public scores are benchmark indicators derived from our interpretation of publicly available evidence at the time of review. They are not credit ratings, ESG ratings, certifications, or assurance statements. Scores reflect the four-stage governance process: AI analyst draft, senior ESG practitioner review, final record approval, and management calibration.